在人类口腔舌头状细胞癌中的节点传播预测使用癌症测试剂抗原基因签名
Yoav Smith1, Amit Cohen1, Tzahi Neuman2,3
1Genomic Data Analysis Unit, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
International journal of molecular sciences
|September 27, 2025
概括
识别特定的癌症丸抗原 (CTA) 可以预测宫淋巴结转移在口腔舌癌. 这种生物标志物方法可以减少不必要的部剖析和手术副作用.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物标志物发现发现
背景情况:
- 宫淋巴结转移是口舌癌的关键预后因素.
- 目前关于部解剖的指导方针,基于入侵深度,导致高达70%的患者过度治疗.
- 癌症丸抗原 (CTA) 涉及到瘤的攻击性和潜在的结节传播.
研究的目的:
- 在口腔舌癌中识别活跃的CTA基因.
- 评估CTAs对宫淋巴结转移的预测能力.
- 开发一种基于CTA的诊断工具,以尽量减少不必要的部解剖.
主要方法:
- 公共数据集的多步分析 (微阵列,TCGA,scRNA-seq).
- 使用NanoString nCounterRNA分析对16名患者进行验证.
- 机器学习算法的应用 (决策树,t-SNE,CNN) 用于预测分析.
主要成果:
- 确定了40个癌症活性CTA基因;四个 (LY6K,MAGEA3,CEP55,ATAD2) 是最能表明结节传播的.
- 纳米字符串分析和机器学习证实了这四个CTA高度预测转移.
- 开发了一个基于CTA的诊断工具,用于结节参与的概念验证.
结论:
- 由四个CTA (LY6K,MAGEA3,CEP55,ATAD2) 组成的小组可以准确预测口腔舌癌中宫淋巴结转移的情况.
- 这种基于CTA的方法提供了一个潜在的策略,以减少不必要的部解剖和相关的发病率.
- 生物标志物引导诊断是口腔癌管理的一个有希望的进步.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.2K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.8K
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
